The utility of imaging findings using new sequence of MRI in brain tumor

The utility of imaging findings using new sequence of MRI in brain tumor - The utility of imaging findings using new sequence of MRI in brain tumor

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036504

Enrollment

Registered

2019-04-15

Start date

2019-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who agree and write informed consent form If subjects are child, their parent or guardian write informed consent form 2) patient who undergo MRI imaging for medical treatment 3) patients who have brain tumors or are suspected to have brain tumors 4) patient who received chemotherapy and radiation therapy after brain tumor surgery

Exclusion criteria

Exclusion criteria: 1) patients who cannot lie down for 1 hour 2) pregnant patients 3) claustrophobia 4) patients who are considered not to be suitable for the research by research representative

Design outcomes

Primary

Measure	Time frame
1)To correlate signal intensity of APT imaging and histopathological findings in brain tumor. 2)To correlate signal intensity of APT imaging and imaging findings on other sequences after chemotherapy and/or radiation therapy. 3)To correlate signal intensity of eASL and histopathological findings in brain tumor. 4)To correlate signal intensity of eASL and imaging findings on other sequences after chemotherapy and/or radiation therapy.	—

Measure

Time frame

1)To correlate signal intensity of APT imaging and histopathological findings in brain tumor. 2)To correlate signal intensity of APT imaging and imaging findings on other sequences after chemotherapy and/or radiation therapy. 3)To correlate signal intensity of eASL and histopathological findings in brain tumor. 4)To correlate signal intensity of eASL and imaging findings on other sequences after chemotherapy and/or radiation therapy.

—

Secondary

Measure	Time frame
1) To correlate signal intensity of eASL and conventional ASL. 2) To compare the image quality of eASL and signal intensity of dynamic susceptibility contrast in brain tumor.	—

Countries

Japan

Contacts

Public ContactShinya Fujii

Tottori university Department of radiology

sfujii@tottori-u.ac.jp0859-38-6637

Outcome results